Commentary So far in 2022, the Chinese stock market has outperformed expectations.  After spending most of 2021 on the “uninvestable” list, Chinese stocks have been boosted by two external developments. Last year was punishing for most investors with mainland Chinese exposure. Besides China’s uneven economic recovery due to its restrictive COVID policies, regulators spent the majority of 2021 cracking down on China’s real estate and technology sectors. Heading into 2022, a few Wall Street analysts began recommending Chinese stocks, including bullish analysts at Credit Suisse and BlackRock. More than two months into the year, more support is coming from unlikely places. The first is policy driven. After a busy regulatory year in 2021 as the Chinese Communist Party (CCP) introduced new legislation restricting technology companies and forced deleveraging of the real estate developers, 2022 will likely be muted on the regulatory front.  Policy uncertainty is expected to subside this year …